Katherine Pawelczak
Principal investigator, leads NERX BIOSCIENCES, INC..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$3.2MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $3.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 21, 2025 | NIH | SBIR Phase II Targeting the DNA Damage Response sensor Replication Protein A for first inclass cancer therapy | $921K | NERX BIOSCIENCES, INC. |
| Aug 1, 2024 | NIH | SBIR Phase II Targeting the DNA Damage Response sensor Replication Protein A for first inclass cancer therapy | $1.1M | NERX BIOSCIENCES, INC. |
| Sep 1, 2017 | NIH | SBIR Phase I Development of novel Ku targeted kinase inhibitors | $300K | NERX BIOSCIENCES, INC. |
| Jan 13, 2017 | NIH | STTR Phase I A new generation of targeted therapeutics for the treatment of cancer. | $50K | NERX BIOSCIENCES, INC. |
| Jun 1, 2016 | NIH | SBIR Phase I Chemical enhancement of CRISPR/Cas9 mediated site-specific genome engineering | $293K | NERX BIOSCIENCES, INC. |
| Jun 1, 2015 | NIH | STTR Phase I A new generation of targeted therapeutics for the treatment of cancer | $299K | NERX BIOSCIENCES, INC. with INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS |
| May 15, 2015 | NIH | STTR Phase I Development of novel lung cancer therapeutics targeting the DNA damage response | $249K | NERX BIOSCIENCES, INC. |
Peer ranks
Federal funding#562
Awards as PI#250
Patents#273
Companies
- NERX BIOSCIENCES, INC.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.